This research study is currently not recruiting patients.

Controlled Trial of 3 4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome (LEMS)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lambert-Eaton Myasthenic Syndrome (LEMS) | Lambert-Eaton Myastenic Syndrome
  • Age: Between 4 - 100 Years
  • Gender: Male or Female
Inclusion Criteria
Diagnosed with Lambert-Eaton Myasthenic Syndrome
If female, have a negative pregnancy test and, if premenopausal, be willing to practice and effective form of birth control during this treatment
Exclusion Criteria
Known sensitivity to 3,4-DAP
Has a history of past or current seizures or of severe asthma
Is believed by the investigator to be unable to comply with the protocol


Not Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.